GB1359226A - Propylene carbonate medicament base composition - Google Patents

Propylene carbonate medicament base composition

Info

Publication number
GB1359226A
GB1359226A GB4193171A GB4193171A GB1359226A GB 1359226 A GB1359226 A GB 1359226A GB 4193171 A GB4193171 A GB 4193171A GB 4193171 A GB4193171 A GB 4193171A GB 1359226 A GB1359226 A GB 1359226A
Authority
GB
United Kingdom
Prior art keywords
weight percent
alkyl
alcohols
propylene carbonate
polysiloxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4193171A
Other languages
English (en)
Inventor
S Shastri
Z I Shaikh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Palo Alto LLC
Original Assignee
Roche Palo Alto LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Palo Alto LLC filed Critical Roche Palo Alto LLC
Publication of GB1359226A publication Critical patent/GB1359226A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB4193171A 1970-10-29 1971-09-08 Propylene carbonate medicament base composition Expired GB1359226A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8524670A 1970-10-29 1970-10-29

Publications (1)

Publication Number Publication Date
GB1359226A true GB1359226A (en) 1974-07-10

Family

ID=22190384

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4193171A Expired GB1359226A (en) 1970-10-29 1971-09-08 Propylene carbonate medicament base composition

Country Status (17)

Country Link
JP (1) JPS5410613B1 (enExample)
AT (1) AT310948B (enExample)
BE (1) BE774489A (enExample)
CA (1) CA989306A (enExample)
CH (1) CH566783A5 (enExample)
DE (1) DE2153779C3 (enExample)
DK (1) DK129766B (enExample)
ES (2) ES396479A1 (enExample)
FI (1) FI52811C (enExample)
FR (1) FR2111912B1 (enExample)
GB (1) GB1359226A (enExample)
IL (1) IL37614A (enExample)
NL (1) NL164199C (enExample)
NO (1) NO133998C (enExample)
SE (1) SE377042B (enExample)
YU (1) YU268471A (enExample)
ZA (1) ZA715709B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116423A (en) * 1982-01-13 1983-09-28 Quinoderm Ltd Dermatological compositions
US4626529A (en) * 1981-10-23 1986-12-02 L'oreal Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin
EP2319510A1 (en) * 2009-10-02 2011-05-11 Johnson and Johnson Consumer Companies, Inc. Benzoyl peroxide composition for treating skin

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1327853A (en) * 1971-05-24 1973-08-22 Ici Ltd Griseofulvin compositions
FR2205358B1 (enExample) * 1972-11-03 1976-04-23 Rhone Poulenc Ind
US4070462A (en) * 1976-10-26 1978-01-24 Schering Corporation Steroid ointment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626529A (en) * 1981-10-23 1986-12-02 L'oreal Oily compositions comprising a dermatological active principle, intended for the treatment of the scalp or skin
GB2116423A (en) * 1982-01-13 1983-09-28 Quinoderm Ltd Dermatological compositions
EP2319510A1 (en) * 2009-10-02 2011-05-11 Johnson and Johnson Consumer Companies, Inc. Benzoyl peroxide composition for treating skin

Also Published As

Publication number Publication date
FR2111912A1 (enExample) 1972-06-09
CH566783A5 (enExample) 1975-09-30
CA989306A (en) 1976-05-18
AU3322871A (en) 1973-03-15
DE2153779B2 (de) 1974-08-29
NO133998B (enExample) 1976-04-26
NL7114957A (enExample) 1972-05-03
ES423345A1 (es) 1976-06-01
FI52811C (fi) 1977-12-12
YU268471A (en) 1984-06-30
NL164199C (nl) 1980-12-15
BE774489A (fr) 1972-02-14
DK129766C (enExample) 1975-04-28
IL37614A (en) 1974-05-16
DE2153779A1 (de) 1972-06-08
JPS5410613B1 (enExample) 1979-05-08
NO133998C (enExample) 1976-08-04
DK129766B (da) 1974-11-18
IL37614A0 (en) 1971-11-29
DE2153779C3 (de) 1975-04-24
FI52811B (enExample) 1977-08-31
AT310948B (de) 1973-10-25
ES396479A1 (es) 1975-02-16
ZA715709B (en) 1972-11-29
FR2111912B1 (enExample) 1975-02-07
SE377042B (enExample) 1975-06-23

Similar Documents

Publication Publication Date Title
ES8505249A1 (es) Procedimiento para obtener medicamentos altamente solubles por atomizacion en presencia de un estabilizante y un agente inhibidor de formacion de cristales.
DE3851152D1 (de) Cyclosporin-augenmittel.
LU90677I2 (fr) Esomeprazole et ses sels et d-riv-s pharmaceutiquement acceptables (nexiam)
HUT49280A (en) Ointment for the peroral administration of medicine and process for producing the composition
ES8507573A1 (es) Procedimiento para la fabricacion de fracciones de acido hialuronico
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
PT71727A (en) Process for preparing a pharmaceutical composition particularly suitable for cancer treatment
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
IL58782A (en) Hydroxypropyl-triazole compounds,their production and pharmaceutical compositions containing them
IT1261955B (it) Soluzione di farmaci in particolare piroxicam con stabilita' aumentatae senza effetto dannoso sui tessuti e procedimento per la loro preparazione
BR9509019A (pt) Processo para fabricar unidades de dosagem farmacêutica e comprimido isento de solventes orgânicos
US2730483A (en) Therapeutic compositions comprising neomycin, gramicidin and quaternary ammonium salt of thonzylamine
PE33396A1 (es) Composicion para el tratamiento del ansia de nicotina y/o los sintomas de abstinencia de fumar
US3888995A (en) Fatty alcohol-propylene glycol vehicle
EP0158102A3 (en) New (8s)-8-fluoroerythromycin derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
IE40957L (en) 4- o-ó,d-glucopyranosyl -6-o-ó,d- xylohexopyranosyl -2-¹deoxystreptamine
PE13395A1 (es) Composicion farmaceutica de imidazolil carbazolona
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
AR017215A1 (es) Composiciones que contienen generadores de oxido nitrico y uso de dichos generadores para la preparacion de un medicamento util para el tratamiento detrastornos de ojo seco
GB1454389A (en) Nasal decongestants nasal decongestants
GB843136A (en) Improvements in and relating to pharmaceutical compositions
ES421570A1 (es) Un procedimiento para la preparacion de nuevos derivados de cianopregnenona.
GB843134A (en) Improvements in and relating to pharmaceutical compositions
HUT59597A (en) Process for producing pharmaceutical compositions contaiing pharmaceutically active tetrahydro-naphtalene derivatives
GB2012166A (en) Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE20 Patent expired after termination of 20 years